Summit Partners has announced a growth investment in Dreampath Diagnostics.
Dreampath, founded in 2012, headquartered in Strasbourg, France, and with a U.S. commercial office in New York, provides digital sample management systems for anatomical pathology laboratories.
Summit, founded in 1994 and based in Boston, pursues opportunities in healthcare services, healthcare technology and life sciences as well as in other growth sectors. The firm typically targets growth equity and fixed income investments between $10 million and $500 million.
Terms of the investment were not disclosed.
